BioCrossroads’ new talent program recognizes the next generation of life sciences leaders 23 PAIRs (Promising Achievers in Innovation and Research) nominations are open

BioCrossroads 23 PAIR award

INDIANAPOLIS, (June 2, 2022) — People are the most valuable resource to Indiana’s life sciences sector — those who are innovating, discovering, developing and delivering critical pharmaceuticals and biotech products, medical devices, equipment, and diagnostics as well as researching and creating new protocols to accelerate getting life improving and lifesaving products to patients all over the […]

Indiana’s life sciences companies accessed more than $15 billion to grow innovation in 2021

BioCrossroads Life Sciences Capital Report 2021

INDIANAPOLIS (April 19, 2022) – More than $15 billion of capital was accessed by Indiana’s life sciences companies in 2021. BioCrossroads today issued their annual report, Indiana Life Sciences Capital 2021, which provides details on the funding events throughout the year, including: $6.5 million in Small Business Innovation Research (SBIR) awards to 17 companies A record […]

BioCrossroads releases 2021 annual report

In addition to global health contributions through medical innovations such as the manufacturing of three COVID-19 vaccines, Indiana’s vibrant and unique life sciences industry continues to make a significant impact on the state through its economic strength, contributing more than $79 billion in 2021. In 2021, BioCrossroads focused on collaborations among industry, academic, government and […]

IIB: BioCrossroads Celebrates 20 Years of Growing State’s Life Sciences Sector

BioCrossroads marks 20 years in the life sciences

BioCrossroads, the life sciences initiative of the Central Indiana Corporate Partnership (CICP), is marking 20 years of growing the sector in Indiana. In that time, the life sciences sector in the state has grown to be an $80 billion industry. BioCrossroads has also invested in more than 500 startups through three venture capital funds. BioCrossroads […]

BioCrossroads celebrates two decades of advancing Indiana’s life sciences sector

BioCrossroads celebrates 20th anniversary

INDIANAPOLIS (Feb. 14, 2022)  ̶  Back in the early 2000’s no one had a doubt that Indiana was home to world-class life sciences assets, but the community was missing the opportunity to collectively advance its strengths. A coalition of organizations and business leaders decided to ensure that Central Indiana and the entire state, took advantage […]

Pharmaceutical investments lead 2021 life sciences growth in Indiana

2021 Indiana life sciences investments

INDIANAPOLIS (Feb. 2, 2022)  ̶  In 2021, Indiana’s life sciences industry experienced strong growth in the attraction and expansion of companies across the state. Twenty-three companies committed to invest over $500 million and hire 2,100 employees. Of those 23 companies, nine committed to invest over $10 million each and two others will invest over $100 […]

BioCrossroads’ seed capital strategy connects funding with innovation

Supporting Life Sciences: A look back at BioCrossroads’ capital strategy

INDIANAPOLIS (Oct. 27, 2021) — For nearly 20 years, BioCrossroads has demonstrated a track record of organizing, developing and managing seed-stage and venture capital funds for Indiana-based life sciences start-ups. BioCrossroads’ three Indiana Seed Funds, totaling $24.25 million, have invested in 32 life sciences start-ups since 2006. Those companies have gone on to raise an additional […]

Purdue chemistry professor and founder of Inotiv, Dr. Peter Kissinger, honored as 2021 Watanabe Life Sciences Champion of the Year

Dr. Peter Kissinger

INDIANAPOLIS (Oct. 13, 2021) — BioCrossroads’ Board of Directors named educator, innovator and researcher Dr. Peter Kissinger as the recipient of the 2021 August M. Watanabe Life Sciences Champion of the Year Award. The prestigious honor, named in tribute to BioCrossroads’ late Chairman August Watanabe, was given to Dr. Kissinger at today’s Indiana Life Sciences Summit. […]